Climate Health Pharma

WHO keeping an eye on a surge of respiratory illness in northern China

The World Health Organization is monitoring an increase in children’s illness caused by pathogens, including acute respiratory syndrome coronavirus 2, in northern China.

Read More
Drugs Health Pharma

Novo Nordisk invests $2.3b in France for diabetes, obesity drugs

HQ Team November 23, 2023: Novo Nordisk will invest $2.3 billion to expand production of its weight-loss and diabetes drug in Chartes, France..

Read More
Drugs Health Pharma

Vampiric tumour cells can hijack human body’s immune cell energy

HQ Team November 22, 2023: Tumour molecules can rob the human body’s immune cells to deprive them of their energy to fuel the.

Read More
Drugs Medical Pharma

Zevra Therapeutics completes acquisition of Acer in a $91m deal

HQ Team November 21, 2023: Zevra Therapeutics, Inc. has finalized its acquisition of Acer Therapeutics Inc in a $91m deal. This strategic acquisition.

Read More
Drugs Health Pharma

Opinion: Food poisoning, deaths took shawarma out of my food menu

By Dr. K. Leelamoni November 21, 2023: Shawarma was a favourite dish of mine and I first came to know about it when.

Read More
Drugs Medical Pharma

Bayer aborts late-stage trial of anticoagulant drug due to inefficacy

HQ Team November 20, 2023: Bayer, the pharmaceutical giant, has decided to halt a large late-stage trial for its experimental anticoagulant drug, asundexian..

Read More
Health Medical Pharma

Micron gets $23.6m Gates Foundation grant to make needle-free vaccines

HQ Team November 20, 2023: Micron Biomedical, a US Atlanta-based medical device company, announced a $23.6 million grant from the Bill & Melinda.

Read More
Drugs Health Pharma

Lilly to build $2.5b plant in Germany to make diabetes, obesity devices

HQ Team November 18, 2023: Eli Lilly, a US company that forecasts revenue of up to $33.9 billion, plans to build a $2.5.

Read More
Drugs Health Pharma

Astellas’ prostate cancer drug for metastasis-free survival gets nod

HQ Team November 18, 2023: The Food and Drug Administration (FDA) has green-lighted Astellas Pharma’s prostrate cancer drug Xtandi five weeks ahead of.

Read More
Health Medical Pharma

WHO rejects setting up ‘safe zone’ in Gaza, says ‘broad agreement’ needed

HQ Team November 18, 2023: A plan to create a safe zone at Gaza’s Al-Mawasi is a “recipe for disaster” and the WHO.

Read More
X